Literature DB >> 8548404

Secretion of human monocyte mature IL-1 beta: optimization of culture conditions and inhibition by ICE inhibitors.

J Uhl1, P Krasney, L Brophy, R Arnold, R Dolle, C Helaszek, R Miller, S Gilman, M Ator.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8548404     DOI: 10.1007/bf01778338

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  5 in total

1.  Identification of IL-1 receptors on human monocytes.

Authors:  J Uhl; R C Newton; J G Giri; G Sandlin; R Horuk
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

2.  A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.

Authors:  N A Thornberry; H G Bull; J R Calaycay; K T Chapman; A D Howard; M J Kostura; D K Miller; S M Molineaux; J R Weidner; J Aunins
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

3.  Identification of a monocyte specific pre-interleukin 1 beta convertase activity.

Authors:  M J Kostura; M J Tocci; G Limjuco; J Chin; P Cameron; A G Hillman; N A Chartrain; J A Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  P1 aspartate-based peptide alpha-((2,6-dichlorobenzoyl)oxy)methyl ketones as potent time-dependent inhibitors of interleukin-1 beta-converting enzyme.

Authors:  R E Dolle; D Hoyer; C V Prasad; S J Schmidt; C T Helaszek; R E Miller; M A Ator
Journal:  J Med Chem       Date:  1994-03-04       Impact factor: 7.446

5.  The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta.

Authors:  D J Hazuda; J C Lee; P R Young
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

  5 in total
  1 in total

1.  Increased expression of IL-1beta converting enzyme in hippocampus after ischemia: selective localization in microglia.

Authors:  R V Bhat; R DiRocco; V R Marcy; D G Flood; Y Zhu; P Dobrzanski; R Siman; R Scott; P C Contreras; M Miller
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.